Differential membrane binding of the human immunodeficiency virus type 1 matrix protein

Journal of Virology

Volumn 70, Issue 12, 1996, Pages 8540-8548

  Zhou, Wenjun ^a   Resh, Marilyn D ^a,b  

^a Weill Cornell Graduate School of Biomedical Sciences   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOSOME; MATRIX PROTEIN; VIRUS PROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING AFFINITY; CELLULAR DISTRIBUTION; CONFORMATIONAL TRANSITION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MEMBRANE BINDING; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN STRUCTURE;

EID: 0029861657     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.12.8540-8548.1996     Document Type: Article

References (48)

1. Barenholz, Y., D. Gibbes, B. J. Litman, J. Goll, T. E. Thompson, and F. D. Carlson. 1977. A simple method for the preparation of homogeneous phospholipid vesicles. Biochemistry 16:2806-2810.
2. Bennett, R. P., T. D. Nelle, and J. W. Wills. 1993. Functional chimeras of the Rous sarcoma virus and human immunodeficiency virus Gag proteins. J. Virol. 67:6487-6498.
3. Boman, A. L., and R. A. Kahn. 1995. Arf proteins: the membrane traffic police? Trends Biochem. Sci. 20:147-150.
4. Bryant, M., and L. Ratner. 1990. Myristoylation-dependent replication and assembly of human immunodeficiency virus 1. Proc. Natl. Acad. Sci. USA 87:523-527.
5. Bukrinskaya, A. G., G. K. Vorkunova, and Y. Y. Tentsov. 1992. HIV-1 matrix protein p17 resides in cell nuclei in association with genomic RNA. AIDS Res. Hum. Retroviruses 8:1795-1801.
6. Bukrinsky, M. I., S. Haggerty, M. P. Dempsey, N. Sharova, A. Adzhubei, L. Spitz, P. Lewis, D. Goldfarb, M. Emerman, and M. Stevenson. 1993. A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells. Nature (London) 365:666-669.
7. Bukrinsky, M. I., N. Sharova, M. P. Dempsey, T. L. Stanwick, A. G. Bukrinskaya, S. Haggerty, and M. Stevenson. 1992. Active nuclear import of human immunodeficiency virus type 1 preintegration complex. Proc. Natl. Acad. Sci. USA 89:6580-6584.
8. v-src: myristylation in a cell-free system. Mol. Cell. Biol. 8:4295-4301.
9. Freed, E. O., G. Englund, and M. A. Martin. 1995. Role of the basic domain of human immunodeficiency virus type 1 matrix in macrophage infection. J. Virol. 69:3949-3954.
10. Gallay, P., S. Swingler, C. Aiken, and D. Trono. 1995. HIV-1 infection of nondividing cells: C-terminal tyrosine phosphorylation of the viral matrix protein is a key regulator. Cell 80:379-388.
11. Gallay, P., S. Swingler, J. Song, F. Bushman, and D. Trono. 1995. HIV nuclear import is governed by the phosphotyrosine-mediated binding of matrix to the core domain of integrase. Cell 83:569-576.
12. Gelderblom, H. R. 1991. Assembly and morphology of HIV: potential effect of structure on viral function. AIDS 5:617-638.
13. gag virus-like particles from recombinant baculovirus-infected insect cells. Cell 59:103-112.
14. Göttlinger, H. G., T. Dorfman, J. G. Sodroski, and W. A. Haseltine. 1991, Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release. Proc. Natl. Acad. Sci. USA 88:3195-3199.
15. Göttlinger, H. G., J. G. Sodroski, and W. A. Haseltine. 1989. Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 86:5781-5785.
16. Heim, R., A. B. Cubitt, and R. Y. Tsien. 1995. Improved green fluorescence. Nature (London) 373:663-664.
17. Heinzinger, N. K., M. I. Bukrinsky, S. A. Haggerty, A. M. Ragland, V. Kewalramani, M.-A. Lee, H. E. Gendelman, L. Ratner, M. Stevenson, and M. Emerman. 1994. The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. Proc. Natl. Acad. Sci. USA 91:7311-7315.
18. Kalderon, D., B. L. Roberts, W. D. Richardson, and A. E. Smith. 1984. A short amino acid sequence able to specify nuclear location. Cell 39:499-509.
19. Klapper, A., B. MacKay, and M. D. Resh. 1992. Rapid high resolution western blotting: from gel to image in a single day. BioTechniques 12:652-654.
20. LeGendre, N. 1990. Immobilon-P™ transfer membrane: applications and utility in protein biochemical analysis. BioTechniques 9:788-805.
21. Lewis, P. F., and M. Emerman. 1994. Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus. J. Virol. 68:510-516.
22. Lu, Y.-L., P. Spearman, and L. Ratner. 1993. Human immunodeficiency virus type 1 viral protein R localization in infected cells and virions. J. Virol. 67:6542-6550.
23. Massiah, M. A., M. R. Starich, C. Paschall, M. F. Summers, A. M. Christensen, and W. I. Sundquist. 1994. Three-dimensional structure of the human immunodeficiency virus type 1 matrix protein. J. Mol. Biol. 244:198-223.
24. Matthews, S., P. Barlow, J. Boyd, G. Barton, R. Russell, H. Mills, M. Cunningham, N. Meyers, N. Burns, N. Clark, S. Kingsman, A. Kingsman, and I. Campbell. 1994. Structural similarity between the p17 matrix protein of HIV-1 and interferon-γ. Nature (London) 370:666-668.
25. Mervis, R. J., N. Ahmad, E. P. Lillehog, M. G. Raum, F. H. R. Salazar, H. G. Chan, and S. Venkatesan. 1988. The gag gene products of human immunodeficiency virus type 1. J. Virol. 62:3993-4002.
26. Myers, G., J. A. Berzofsky, G. N. Pavlakis, B. Korber, and R. F. Smith (ed.), 1992. A compilation and analysis of nucleic acid and amino acid sequences. Los Alamos National Laboratory, Los Alamos, N.M.
27. Parent, L. J., C. B. Wilson, M. D. Resh, and J. W. Wills. 1996. Evidence for a second function of the MA sequence in the Rous sarcoma virus Gag protein. J. Virol. 70:1016-1026.
28. Peitzsch, R. M., and S. McLaughlin. 1993. Binding of acylated peptides and fatty acids to phospholipid vesicles: relevance to myristylaled proteins. Biochemistry 32:10436-10443.
29. gag membrane association in a cell-free system: requirement for a C-terminal domain. Proc. Natl. Acad. Sci. USA 91:4594-4598.
30. Prince, A. M., B. Horowitz, L. Baker, R. W. Shulman, H. Ralph, J. Valinsky, A. Cundell, B. Brotman, W. Boehle, F. Rey, M. Piet, H. Reesink, N. Lelie, M. Tersmette, F. Miedema, L. Barbosa, G. Nemo, C. L. Nastala, J. S. Allan, D. R. Lee, and J. W. Eichberg. 1988. Failure of a human immunodeficiency virus (HIV) immune globulin to protect chimpanzees against experimental challenge with HIV. Proc. Natl. Acad. Sci. USA 85:6944-6948.
31. v-src to plasma membranes: evidence for a myristyl-Src receptor. Cell 58:281-286.
32. c-src molecules. J. Cell Biol. 100:409-417.
33. Schwartz, S., M. Campbell, G. Nasioulas, J. Harrison, B. K. Felber, and G. N. Pavlakis. 1992. Mutational inactivation of an inhibitory sequence in human immunodeficiency virus type 1 results in Rev-independent gag expression. J. Virol. 66:7176-7182.
34. Sigal, C., W. Zhou, C. Buser, S. McLaughlin, and M. D. Resh. 1994. Aminoterminal basic residues of Src mediate membrane binding through electrostatic interaction with acidic phospholipids. Proc. Natl. Acad. Sci. USA 91:12253-12257.
35. v-src. J. Cell Biol. 119:415-425.
36. Spearman, P., J.-J. Wang, N. V. Heyden, and L. Ratner. 1994. Identification of human immunodeficiency virus type 1 Gag protein domains essential to membrane binding and particle assembly. J. Virol. 68:3232-3242.
37. Tanaka, T., J. B. Ames, T. S. Harvey, L. Stryer, and M. Ikura. 1995. Sequestration of the membrane-targeting myristyl group of recoverin in the calcium-free state. Nature (London) 376:444-447.
38. Thelen, M., A. Rosen, A. C. Nairn, and A. Aderem. 1991. Regulation by phosphorylation of reversible association of a myristylated protein kinase C substrate with the plasma membrane. Nature (London) 351:320-322.
39. Towler, D. A., J. I. Gordon, S. P. Adams, and L. Glaser. 1988. The biology and enzymology of eukaryotic protein acylation. Annu. Rev. Biochem. 57:69-99.
40. Vogt, V. Personal communication.
41. von Schwedler, U., R. S. Kornbluth, and D. Trono. 1994. The nuclear localization signal of the matrix protein of human immunodeficiency virus type 1 allows the establishment of infection in macrophages and quiescent T lymphocytes. Proc. Natl. Acad. Sci. USA 91:6992-6996.
42. c-src from the plasma membrane to the cytosol after stimulation by platelet-derived growth factor. J. Biol. Chem. 268:19552-19558.
43. Wills, J. W., and R. C. Craven. 1991. Form, function, and use of retroviral Gag proteins. AIDS 5:639-654.
44. src. J. Virol. 65:3804-3812.
45. Yu, G., F. S. Shen, S. Sturch, A. Aquino, R. I. Glazer, and R. L. Felsted. 1995. Regulation of HIV-1 gag protein subcellular targeting by protein kinase C. J. Biol. Chem. 270:4792-4796.
46. Yuan, X., X. Yu, T.-H. Lee, and M. Essex. 1993. Mutations in the N-terminal region of human immunodeficiency virus type 1 matrix protein block intracellular transport of the Gag precursor. J. Virol. 67:6387-6394.
47. Zhou, W., L. J. Parent, J. W. Wills, and M. D. Resh. 1994. Identification of a membrane binding domain within the amino-terminal region of human immunodeficiency virus type 1 Gag protein which interacts with acidic phospholipids. J. Virol. 68:2556-2569.
48. Zhou, W., and M. D. Resh. 1996. Unpublished results.